NL161759C - PROCESS FOR THE PREPARATION OF SALICYLIC ACID COMPOUNDS, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PRODUCTS PRODUCED THROUGH THE USE THEREOF - Google Patents

PROCESS FOR THE PREPARATION OF SALICYLIC ACID COMPOUNDS, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PRODUCTS PRODUCED THROUGH THE USE THEREOF

Info

Publication number
NL161759C
NL161759C NL6813639.A NL6813639A NL161759C NL 161759 C NL161759 C NL 161759C NL 6813639 A NL6813639 A NL 6813639A NL 161759 C NL161759 C NL 161759C
Authority
NL
Netherlands
Prior art keywords
preparation
salicylic acid
pharmaceutical preparations
acid compounds
products produced
Prior art date
Application number
NL6813639.A
Other languages
Dutch (nl)
Other versions
NL6813639A (en
NL161759B (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL6813639A publication Critical patent/NL6813639A/xx
Publication of NL161759B publication Critical patent/NL161759B/en
Application granted granted Critical
Publication of NL161759C publication Critical patent/NL161759C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL6813639.A 1967-10-06 1968-09-24 PROCESS FOR THE PREPARATION OF SALICYLIC ACID COMPOUNDS, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PRODUCTS PRODUCED THROUGH THE USE THEREOF NL161759C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67327367A 1967-10-06 1967-10-06

Publications (3)

Publication Number Publication Date
NL6813639A NL6813639A (en) 1969-04-09
NL161759B NL161759B (en) 1979-10-15
NL161759C true NL161759C (en) 1980-03-17

Family

ID=24701969

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6813639.A NL161759C (en) 1967-10-06 1968-09-24 PROCESS FOR THE PREPARATION OF SALICYLIC ACID COMPOUNDS, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PRODUCTS PRODUCED THROUGH THE USE THEREOF

Country Status (7)

Country Link
US (1) US3558641A (en)
BR (1) BR6802728D0 (en)
CH (1) CH502981A (en)
DE (1) DE1801303A1 (en)
FR (1) FR1585315A (en)
GB (1) GB1214079A (en)
NL (1) NL161759C (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993763A (en) * 1969-03-18 1976-11-23 Ciba-Geigy Corporation Tertiary aminoacids as anti-inflammatory agents
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
US3676451A (en) * 1970-06-09 1972-07-11 Merck & Co Inc Thiazolylsalicylic acids
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
US3929833A (en) * 1970-10-30 1975-12-30 Sandoz Ag Organic compounds
FR2128285A1 (en) * 1971-03-11 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive mao-inhibitory, anticonvulsant antiinflammatory choleretic and antiviral activity prepn
FR2128292A1 (en) * 1971-03-12 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive, mao-inhibitory, anticonvulsant antiinflammatory, choleretic and antiviral activity prepn
US3860640A (en) * 1972-04-12 1975-01-14 Nippon Shinyaku Co Ltd 3-alkoxy-5-substituted phenylacetic acids
US3865839A (en) * 1973-03-01 1975-02-11 Hoechst Co American Thiopyranopyrrolylsalicyclic acids and derivatives thereof
US4111935A (en) * 1975-01-02 1978-09-05 Smith Kline & French Laboratories Limited 3-chloro-6-phenylpyridazine compounds
GB1560880A (en) * 1975-12-29 1980-02-13 Ici Ltd Diphenylmethane derivatives and pharmaceutical compositions containing them
US4152341A (en) * 1975-12-29 1979-05-01 Imperial Chemical Industries Limited Triaryl or diarylpyridyl methanes
DE2818765A1 (en) * 1978-04-28 1979-11-08 Basf Ag AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE
DE3668450D1 (en) * 1985-03-14 1990-03-01 Smithkline Dauelsberg 5-AMINOSALICYL ACID DERIVATIVES OF NON-STEROIDAL ANTI-FLAMMABLE ACIDS.
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
ES2639863B1 (en) * 2017-03-10 2018-09-20 Universidad De Granada COMPOUNDS FOR THE TREATMENT OF DISEASES CAUSED BY THE ACCUMULATION OF OXALATE

Also Published As

Publication number Publication date
NL6813639A (en) 1969-04-09
DE1801303A1 (en) 1969-06-19
US3558641A (en) 1971-01-26
NL161759B (en) 1979-10-15
FR1585315A (en) 1970-01-16
BR6802728D0 (en) 1973-05-10
CH502981A (en) 1971-02-15
GB1214079A (en) 1970-12-02

Similar Documents

Publication Publication Date Title
NL7706646A (en) PROCEDURE FOR THE PREPARATION OF DIURETICALLY ACTIVE PHARMACEUTICAL PREPARATIONS, THE PRODUCTS OBTAINED BY THEIR APPLICATION, AND PROCESS FOR THE PREPARATION OF DIURETIC ACTUAL COMPOUNDS.
NL161759C (en) PROCESS FOR THE PREPARATION OF SALICYLIC ACID COMPOUNDS, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PRODUCTS PRODUCED THROUGH THE USE THEREOF
NL157192B (en) PROCESS FOR THE PREPARATION OF HERBICIDE PREPARATIONS.
NL146709B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH BETA-ADRENOLYTIC ACTION, THE MEDICINAL PRODUCTS OBTAINED BY THE APPLICATION OF THIS PROCESS, AND A PROCESS FOR PREPARING BETA-ADRENOLYTIC ALPINE-2-PHENOLYTIC ACTIVE ALXANDRO-3-PHEN-3-PHENROXANDY-3-ALXANDROXAMINES
NL144944B (en) PROCESS FOR THE PREPARATION OF 6-AMINOPENICILLAAN ACID DERIVATIVES.
NL144486B (en) PROCESS FOR PREPARING PHARMACEUTICAL AND VETERINARY PREPARATIONS.
NL145456B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING ANTI-DIARRHEA POLYMERS.
NL158386B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, THE FORMED PRODUCTS OBTAINED BY THEIR APPLICATION, AND PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE 1H-1,5-BENZODIAZEPINE-2,4-DIION DERIVATIVES.
NL154216B (en) PROCESS FOR THE PREPARATION OF CARBAMOYLOXYBENZODIOXOLS AND OF PREPARATIONS CONTAINING THEM.
NL148037B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND THE ARTICLES MANUFACTURED BY THEIR USE, AND PROCEDURE FOR PREPARING ANTI-INFLAMMATORY, ANALGESIC, ANTIPYRETIC AND ANTIPPURITIC COMPOUNDS.
NL7512107A (en) PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATORY PHARMACEUTICAL PREPARATIONS, THE OBJECTS OBTAINED BY THEIR APPLICATION AND PROCESS FOR THE PREPARATION OF COMPOUNDS WITH ANTI-INFLAMMATORY ACTION.
NL150798B (en) PROCESS FOR THE PREPARATION OF 7-AMINOCEPHALOSORANIC ACID AND ITS DERIVATIVES.
NL142949B (en) PROCESS FOR PREPARING SALICYLATE DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PREPARATIONS SO OBTAINED.
NL172446C (en) PROCESS FOR THE PREPARATION OF 4-ARYL-1- (4,4-DIARYLBUTYL) 4-HYDROXYPIPERIDINES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL170852C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATIC ACTIVE P-ISOINDOLINYLPHENYLACACIC ACID AND ITS DERIVATIVES.
NL153084B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE ORAL TREATMENT OF SEBORRHOEA, AND THE PREPARATIONS OBTAINED.
NL150434B (en) PROCESS FOR THE PREPARATION OF ETHIONIC ACID.
NL166267C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, THE PRODUCTS PRODUCED THEREOF, AND PROCESS FOR THE PREPARATION OF 6,7-METHYLENE-20-SPIROX-4-AND-3-RINDERMONDERED PRODUCTS.
NL162079C (en) PROCESS FOR PREPARING (CIS-1,2-EPOXYPROPANE) PHOSPHONIC ACID COMPOUNDS; PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND THE PRODUCTS PRODUCED THROUGH THE USE THEREOF
NL145217B (en) PROCESS FOR THE PREPARATION OF MIXTURES OF PRINCIPLY EPSILON-HYDROXYCAPRONIC ACID.
NL162647C (en) PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATIC ACTIVE PHARMACEUTICAL PREPARATIONS, THE PRODUCTS PRODUCED THEREOF, AND PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATIC ACTIVATED PHENYLATIVES.
NL156752B (en) A PROCESS FOR THE PREPARATION OF AN ANTIBIOTIC, A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, AND PREPARED PRODUCTS USED BY THE USE OF THIS PROCESS.
NL142052B (en) PROCESS FOR THE PREPARATION OF FUNGICIDE PREPARATIONS.
NL141760B (en) PROCESS FOR THE PREPARATION OF HERBICIDE PREPARATIONS.
NL165129C (en) PROCESS FOR THE PREPARATION OF TITANIUM DIOXIDE.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: MERCK